Delivery Order SPE2DB22D1052-SPE2DB25FU9SA
- Not listed
- The Defense Logistics Agency awarded a $13,645.30 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $37,836.27 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a $1,724.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $2,069.70 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was issued on July 21, 2025, and the product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $6,899.00, with completion due by August 1, 2025. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $2,759.60 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $3,827.28 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 31, 2025, with completion targeted for August 1, 2025. This firm fixed price delivery order, awarded without set-aside designation through competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- This delivery order, awarded July 23, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $18,963.22 with completion scheduled for July 24, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,892.26 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $24,644.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 13, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. Performance will be executed at the contractor's facility in Conshohocken,...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FU9SADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,759.60 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 31, 2025. This non-set-aside, firm fixed price delivery order represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract utilizes AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly for Defense Health Agency and military healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for TYPHIM VI vaccine syringes aligns with the company's established role as a primary pharmaceutical distributor supporting the department's medical supply chain requirements and reflects the company's ongoing competitive capability to fulfill federal procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/30/25 |